Surgeon Profile

This survey is completely ANONYMOUS. We cannot recognize who is responding. Please keep this in mind as you answer the questions.

An analysis of the responses to this survey will be included in the next issue of ISAPS News. Please take a few minutes to respond to our questions.

Thank you for your time.
Felmont Eaves, III, MD
ISAPS Survey Editor

Question Title

* 1. Are you an ISAPS member?

Question Title

* 2. Where do you practice?

Question Title

* 3. If you parctice in North America, please check all societies to which you belong on the list below.

Question Title

* 4. How many years have you been in practice?

Question Title

* 5. Please select the category that best describes your practice.

Question Title

* 6. The most common type of implant that you currently use in your practice is:

Question Title

* 7. The most common type of implant that you see in patients presenting for SECONDARY procedures is:

Question Title

* 8. The most common late indications (3 months or later after implant placement) for secondary implant surgery in your practice are: (please rank complications you see on a scale of 1-6).

  1 Most Common 2 3 Least Common
Capsular contracture
Implant malposition
Infection
Extrusion/Exposure
Seroma
Desire for change in implant size

Question Title

* 9. When presented with a patient with capsular contracture, your first treatment attempt is usually:

Question Title

* 10. When performing an open secondary procedure to treat a significant capsular contracture (e.g. Baker IV), you most commonly perform:

Question Title

* 11. When performing a capsulectomy for capsular contracture, do you use drains?

Question Title

* 12. When performing a capsulectomy for capsular contracture, do you send the capsule for pathological analysis?

Question Title

* 13. In a patient undergoing capsulectomy or capsulotomy for capsular contracture, have you ever had a positive tissue culture or capsule pathology result as below?: (Check all that apply.)

Question Title

* 14. In your own patients or in patients previously operated on by another surgeon, have you seen incidence of a late seroma (3 months or more postoperatively) developing in the breast (not donor site) after implant placement?

Question Title

* 15. How many patients IN TOTAL have you treated with late (3 months or more postoperatively) seroma of the breast with implants in place?

Question Title

* 16. If you have observed late (3 months or more) seromas of the breast with implants placed in the following positions, check all that apply.

Question Title

* 17. If you have seen patients with late (3 months or more post-implantation) seromas with the following types of implant surfaces, check all that apply.

Question Title

* 18. If a patient presented with a late seroma (3 or months after implantation), your initial treatment would be:

Question Title

* 19. If a patient presented with a late seroma and no other clinical findings, you would:

Question Title

* 20. If a patient presented with a late seroma (3 or more months after implantation) around a breast implant, would you obtain cultures of the seroma fluid?

Question Title

* 21. In a patient with a late seroma (3 months or greater after implantation), have you ever had a positive cytology or capsule pathology result in a patient with late seromas around an implant that shows: (Check all that apply.)

Question Title

* 22. In a patient first presenting with an exposed implant shell, your INITIAL treatment would be to:

Question Title

* 23. Have you placed an acellular dermal matrix during secondary surgery with breast implants to control implant position or treat capsular problems, for example in cases of synmastia?

T